Michael D. Clayman, President and CEO at Flexion Therapeutics Inc (FLXN), bought 2,000 shares at $9.51 ($19K) on 2016-05-16, disclosed to the SEC on 2016-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| FLXN | BUY | 2019-05-13 | $100K | — | Filing → |
| FLXN | BUY | 2019-03-13 | $100K | — | Filing → |
| FLXN | SELL | 2019-01-04 | $41K | — | Filing → |